CTOR vs CRON

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 21, 2026

CTOR

41.8
AI Score
VS
CRON Wins

CRON

68.9
AI Score

Investment Advisor Scores

CTOR

42score
Recommendation
HOLD

CRON

69score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric CTOR CRON Winner
Forward P/E 10.101 28.7356 CTOR
PEG Ratio 0 0 Tie
Revenue Growth 0.0% 58.4% CRON
Earnings Growth 0.0% 126.8% CRON
Tradestie Score 41.8/100 68.9/100 CRON
Profit Margin 0.0% 39.1% CRON
Beta 1.00 1.00 Tie
AI Recommendation HOLD BUY CRON

Relative Price Performance (Last 90 Days)

CTOR 1M: -44.8% · 3M: +4.2% CRON 1M: +0.9% · 3M: +17.1%

Current Technical Phase

CTOR

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 26

RSI (14): 26.1 · Price: $0.58

CRON

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (4.8% over 20 days), RSI 56

RSI (14): 56.0 · Price: $3.35

Fundamentals Snapshot

Metric CTOR CRON
Market Cap — —
Forward P/E 5.8 13.1
Trailing P/E — 18.1
Revenue (TTM) — —
Revenue Growth 0.0% 0.6%
Gross Margin 0.7% 0.4%
Operating Margin -6.0% 0.2%
EPS -0.47 0.19
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CRON is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.